EUVIMEDEUVIMED entdecken
Klinische Studie

PET ‐ CT Test Properties for HPV Positive Unknown Primary of the Neck: A FIND Trial Correlative Study

Sharon Tzelnick iD, Ur Metser, Eugene Yu, Christopher M K L Yao iD, David Goldstein, Ilan Weinreb, Bayardo Perez-Ordonez, Jillian Tsai, Ali Hosni, Shao Hui Huang, Scott Bratman, John Kim und 1 weitere

Head & Neck · 2025

DOI: 10.1002/hed.28238 ↗

Kurz gefasst

Klinische Studie in der Zeitschrift Head & Neck, 2025. Verfasst von Sharon Tzelnick und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Otolaryngology - Head and Neck Surgery, Princess Margaret Cancer Centre, University Health Network, University of Toronto, Toronto, Ont…. Hauptthemen laut MEDLINE: Positron Emission Tomography Computed Tomography, Neoplasms, Unknown Primary, Head and Neck Neoplasms, Carcinoma, Squamous Cell. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 18 Literaturangaben. Gefördert von: Princess Margaret Cancer Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Diagnostic test properties for PET‐CT in the setting of carcinoma of unknown primary (CUP) of the head and neck have been previously reported in the setting of limited pathologic correlation resulting in biased reporting. With the advent of transoral robotic techniques such as lingual tonsillectomy, the ability to identify small volume primaries has improved. This study aims to investigate the diagnostic test properties of PET‐CT for carcinomas of unknown primary (CUP) of the head and neck.

Methods

A correlative analysis from our previously published prospective FIND trial between 08/2017 and 12/2019 was performed. Patients with p16 positive cervical nodes and no primary (CUP) on clinical examination or axial imaging were included. PET‐CT images were prospectively reported prior to diagnostic surgery. Diagnostic test properties, based on pathologic correlation, were calculated.

Results

A total of 22 patients were included (N1: 10 [45.5%]; N2: 10 [45.5%]; N3: 2 [9%]). Nineteen (86.3%) patients were male, with a mean age of 59.1 years (range 47–68). Seventeen patients (77.2%) had a confirmation of an oropharyngeal primary after diagnostic transoral surgery: 5 (22.6%) in the ipsilateral palatine tonsil, 9 (41%) in the ipsilateral base of tongue, 2 (9%) with bilateral palatine tonsils, and 1 (4.5%) with ipsilateral palatine tonsil and contralateral base of tongue primary. Focal FDG uptake was reported in 13 patients (59%): 3 (13.6%) were reported positive, 8 (36.4%) were suspicious, and 2 (9%) were asymmetric uptake. Of the PET‐CT positive, suspicious lesions, and asymmetric, 3 (100%), 0 (%), 6 (75%) were true positive, respectively. When all FDG uptake (positive, suspicious, and asymmetric) was classified as positive, the sensitivity, specificity, negative predictive value (NPV), positive predictive value (PPV), and false negative rate (FNR) were 53%, 20%, 11%, 69%, and 47%, respectively.

Conclusions

PET‐CT has an important role in the diagnostic evaluation of carcinoma of unknown primary diagnosis. However, sensitivity and specificity rates may be lower than previously suggested. Treatment planning should be based on pathologic confirmation where possible and not solely on PET‐CT findings.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Positron Emission Tomography Computed TomographyNeoplasms, Unknown PrimaryHead and Neck NeoplasmsCarcinoma, Squamous CellHuman Papillomavirus VirusesPapillomavirus InfectionsPilot ProjectsHumansProspective StudiesMaleFemaleMiddle AgedAgedSensitivity and SpecificityPredictive Value of Tests

Stichwörter der Autor:innen

PET‐CThead and neck canerunknown primary

Autor:innen und Institutionen

  • Department of Otolaryngology - Head and Neck Surgery, Princess Margaret Cancer Centre, University Health Network, University of Toronto, Toronto, Ontario, Canada.
  • Department of Surgical Oncology, Princess Margaret Cancer Centre, University Health Network, Toronto, Ontario, Canada.
  • Joint Department of Medical Imaging, University Health Network, Princess Margaret Hospital, Mount Sinai Hospital and Women's College Hospital, University of Toronto, Toronto, Ontario, Canada.
  • Department of Pathology, University Health Network, Toronto, Ontario, Canada.
  • Department of Radiation Oncology, Princess Margaret Cancer Centre/University of Toronto, Ontario, Canada.
  • Associate Professor, Institute for Health Policy, Management and Evaluation, University of Toronto, Canada.

ORCID-Profile: Sharon Tzelnick, Christopher M K L Yao, John R de Almeida

Förderung

  • Princess Margaret Cancer Foundation

Zitieren

APA

Tzelnick, S., Metser, U., Yu, E., Yao, C. M. K. L., Goldstein, D., Weinreb, I., Perez-Ordonez, B., Tsai, J., Hosni, A., Huang, S. H., Bratman, S., Kim, J., & de Almeida, J. R. (2025). PET ‐ CT Test Properties for HPV Positive Unknown Primary of the Neck: A FIND Trial Correlative Study. Head & Neck. https://doi.org/10.1002/hed.28238

Vancouver

Tzelnick S, Metser U, Yu E, Yao CMKL, Goldstein D, Weinreb I, et al. PET ‐ CT Test Properties for HPV Positive Unknown Primary of the Neck: A FIND Trial Correlative Study. Head & Neck. 2025. doi:10.1002/hed.28238

BibTeX
@article{Tzelnick2025,
  author = {Tzelnick, Sharon and Metser, Ur and Yu, Eugene and Yao, Christopher M K L and Goldstein, David and Weinreb, Ilan and Perez-Ordonez, Bayardo and Tsai, Jillian and Hosni, Ali and Huang, Shao Hui and Bratman, Scott and Kim, John and de Almeida, John R},
  title = {PET ‐ CT Test Properties for HPV Positive Unknown Primary of the Neck: A FIND Trial Correlative Study},
  journal = {Head & Neck},
  year = {2025},
  doi = {10.1002/hed.28238}
}
Kostenlos starten →